Showing results (1501-1510 of 1,659) with videos related to
Sort By:
Pageof 166
Chemmedchem|January 22, 2019
Structure-Activity and Structure-Toxicity Relationships of Peptoid-Based Histone Deacetylase Inhibitors with Dual-Stage Antiplasmodial ActivityMarcel K W Mackwitz, Eva Hesping, Yevgeniya Antonova-Koch, et al.Neurobiology of Disease|June 15, 2018
Does inflammation precede tau aggregation in early Alzheimer's disease? A PET studyPeter Parbo, Rola Ismail, Michael Sommerauer, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 20, 2024
Canagliflozin and iron metabolism in the CREDENCE trialAkihiko Koshino, Hiddo J L Heerspink, Niels Jongs, et al.ACS Infectious Diseases|January 7, 2022
Antiproliferation and Antiencystation Effect of Class II Histone Deacetylase Inhibitors on <i>Acanthamoeba castellanii</i>Ki-Back Chu, Hae-Ahm Lee, Marc Pflieger, et al.Frontiers in Oncology|November 12, 2025
Post-progression outcomes following BCMA-directed CAR T-cell therapy in myeloma: impact of extramedullary and paramedullary diseaseZiad Abuhelwa, Fnu Amisha, Wenyi Fan, et al.Brain : a Journal of Neurology|June 6, 2023
Severe cholinergic terminal loss in newly diagnosed dementia with Lewy bodiesNiels Okkels, Jacob Horsager, Miguel Labrador-Espinosa, et al.Biochemistry|December 26, 2001
Steric hindrance as a basis for structure-based design of selective inhibitors of protein-tyrosine phosphatasesL F Iversen, H S Andersen, K B Møller, et al.European Journal of Medicinal Chemistry|June 7, 2014
Discovery of HDAC inhibitors with potent activity against multiple malaria parasite life cycle stagesFinn K Hansen, Subathdrage D M Sumanadasa, Katharina Stenzel, et al.Birth Defects Research. Part B, Developmental and Reproductive Toxicology|February 25, 2015
Effects of maternal and lactational exposure to 2-hydroxy-4-methoxybenzone on development and reproductive organs in male and female rat offspringNoriko Nakamura, Amy L Inselman, Gene A White, et al.Nature Medicine|August 13, 2025
Virtual reality-based versus standard cognitive behavioral therapy for paranoia in schizophrenia spectrum disorders: a randomized controlled trialUlrik N Jeppesen, Ditte L Vernal, Anne Sofie Due, et al.Pageof 166